
Academic Journal
Q3Journal of Infection and Chemotherapy
About Journal of Infection and Chemotherapy
About Journal of Infection and Chemotherapy
Journal of Infection and Chemotherapy is a peer-reviewed scholarly journal published by Elsevier B.V. (Netherlands). It focuses on Q3. Publication coverage spans 1995-2026.
Key indicators: ISSN 1437-7780, 1341-321X; H-index 79.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (79): Strong citation impact — 79 articles cited at least 79 times each, reflecting solid influence.
Publishing in Journal of Infection and Chemotherapy
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q3. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Journal of Infection and Chemotherapy?
1437-7780, 1341-321X.
Who publishes Journal of Infection and Chemotherapy?
Elsevier B.V..
What are Journal of Infection and Chemotherapy's metrics?
H-index 79.
Is Journal of Infection and Chemotherapy peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Pneumonia and Respiratory Infections; Antibiotic Resistance in Bacteria; Antimicrobial Resistance in Staphylococcus; Antibiotics Pharmacokinetics and Efficacy; Bacterial Identification and Susceptibility Testing; Streptococcal Infections and Treatments.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
2,650.00 USD; 2,480.00 EUR; 2,120.00 GBP; 328,680.00 JPY
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
JIC Award 2008
2009-04 · DOI: 10.1007/s10156-009-0648-1A case of postmalaria neurological syndrome in Japan
Yasutaka Mizuno, Yasuyuki Kato, Shuzo Kanagawa, Koichiro Kudo et al.
2007-01-18 · DOI: 10.1007/s10156-006-0489-0Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice
Shigeru Tansho, Shigeru Abe, Hiroko Ishibashi, Shinichi Torii et al.
2007-01-18 · DOI: 10.1007/s10156-006-0479-2Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma
Hideharu Muto, Shin Kaneko, Takayuki Machino, Yasushi Okoshi et al.
2007-01-18 · DOI: 10.1007/s10156-006-0495-2Current status of measles in Japan: molecular and seroepidemiological studies
Teruo Okafuji, Takao Okafuji, Motoko Fujino, Tetsuo Nakayama et al.
2007-01-18 · DOI: 10.1007/s10156-006-0490-7Neutrophil alkaline phosphatase activity in respiratory viral infection
Masaru Kubota, Tsunekazu Haruta
2007-01-18 · DOI: 10.1007/s10156-006-0480-9Clinical characteristics and outcomes of bacteremia caused by Acinetobacter species other than A. baumannii: comparison with A. baumannii bacteremia
Sang-Ho Choi, Eun Ju Choo, Yee Gyung Kwak, Mi-Young Kim et al.
2007-01-18 · DOI: 10.1007/s10156-006-0488-1Structure-activity relationships between linkage style at the C-3 position and nuclear analogues of C(7)-hydroxyiminoaminothiazol cephalosporins against methicillin-resistantStaphylococcus aureus
Hideaki Hanaki, Hiroshi Akagi, Toshio Otani, Keiichi Hiramatsu et al.
1996-12 · DOI: 10.1007/bf02355134Journal of Infection and Chemotherapy
2015-02-14 · DOI: 10.1007/10156.1437-7780Reviews
Community Reviews
Version History
October 10, 2026 at 3:37 am
October 2, 2026